The prefrontal cortex (PFC) is involved in behavioural control and cognitive processes that are altered in schizophrenia. The brainstem monoaminergic systems control PFC function, yet the cells/networks involved are not fully known. Serotonin (5-HT) and norepinephrine (NE) increase PFC neuronal activity through the activation of a 1 -adrenergic receptors (a 1 ARs) and 5-HT 2A receptors (5-HT 2A Rs), respectively. Neurochemical and behavioural interactions between these receptors have been reported. Further, classical and atypical antipsychotic drugs share nM in vitro affinity for a 1 ARs while having preferential affinity for D 2 and 5-HT 2A Rs, respectively. Using double in situ hybridization we examined the cellular expression of a 1 ARs in pyramidal (vGluT1-positive) and GABAergic (GAD 65/67 -positive) neurons in rat PFC and their co-localization with 5-HT 2A Rs. a 1 ARs are expressed by a high proportion of pyramidal (59-85 %) and GABAergic (52-79 %) neurons. The expression in pyramidal neurons exhibited a dorsoventral gradient, with a lower percentage of a 1 ARpositive neurons in infralimbic cortex compared to anterior cingulate and prelimbic cortex. The expression of a 1A , a 1B and a 1D adrenergic receptors was segregated in different layers and subdivisions. In all them there is a high co-expression with 5-HT 2A Rs (y80 %). These observations indicate that NE controls the activity of most PFC pyramidal neurons via a 1 ARs, either directly or indirectly, via GABAergic interneurons. Antipsychotic drugs can thus modulate the activity of PFC via a 1 AR blockade. The high co-expression with 5-HT 2 ARs indicates a convergence of excitatory serotonergic and noradrenergic inputs onto the same neuronal populations. Moreover, atypical antipsychotics may exert a more powerful control of PFC function through the simultaneous blockade of a 1 ARs and 5-HT 2A Rs.
Introduction
The prefrontal cortex (PFC) is critically involved in many higher brain functions, including cognition, attention and behavioural planning (Fuster, 1997 ; Miller & Cohen, 2001) . Anatomical, cellular and neurochemical alterations of the PFC have been reported in schizophrenia (Harrison, 1999 ; Lewis & Lieberman, 2000 ; Lewis et al. 2005 ; Selemon & Goldman-Rakic, 1999 ; Weinberger et al. 2001) .
The brainstem monoaminergic systems innervate the PFC and modulate the activity of memory networks and animal behaviour (Carli et al. 2006 ; Dalley et al. 2004 ; Ramos & Arnsten, 2007 ; Robbins, 2000 ; Roberts et al. 1994 ; Vijayraghavan et al. 2007 ; Winstanley et al. 2003) .
Particular attention has been paid to the dopaminergic system, which finely tunes the activity of PFC neurons during spatial working memory tasks via D 1 receptors in a bell-shaped manner (Vijayraghavan et al. 2007 ; Williams & Goldman-Rakic, 1995) .
Less is known of the role of norepinephrine (NE) and serotonin (5-HT) in PFC function. Hence, moderately elevated levels of NE acting on a 2A -adrenergic receptors (a 2A ARs) improve cognitive performance whereas high NE release (e.g. as evoked by stress) impairs cognitive performance by activating a 1 ARs (Ramos & Arnsten, 2007) . On the other hand, 5-HT 2A R blockade partly antagonizes the neuronal activation during a spatial working-memory task (Williams et al. 2002) and serotonin (5-HT) depletion in monkey orbitofrontal cortex impaired reversal learning (Clarke et al. 2004) . Further, the local blockade of PFC 5-HT 2A Rs improves visuospatial attention and decreases impulsivity in rats (Winstanley et al. 2003) .
Electrophysiological studies in rodents have shown that NE and 5-HT can modulate the activity of PFC neurons in vivo and in vitro (Aghajanian & Marek, 1997 ; Araneda & Andrade, 1991 ; Arvanov et al. 1999 ; Ashby et al. 1989 ; Férézou et al. 2002 ; McCormick et al. 1993 ; Puig et al. 2003 Puig et al. , 2004 Puig et al. , 2005 Tanaka & North, 1993 ; Zhang & Arsenault, 2005 ; Zhou & Hablitz, 1999) . In particular, the excitatory actions of NE and 5-HT on PFC cells may be involved in the maintenance of activity patterns during working-memory tasks. These excitatory actions are mediated by a 1 ARs and 5-HT 2A Rs, respectively (Aghajanian & Marek, 1997 ; Araneda & Andrade, 1991 ; Puig et al. 2003 Puig et al. , 2005 Zhang & Arsenault, 2005) . Additionally, 5-HT can excite GABAergic interneurons via 5-HT 3 receptors (Gui et al. 2010 ; Puig et al. 2004) .
The knowledge of the cellular and network basis of NE and 5-HT modulation of PFC activity is also important in clarifying the mechanism of action of antipsychotic drugs. Hence, classical antipsychotics show high affinity for D 2 receptors, whereas atypical antipsychotics show preferential affinity for 5-HT 2A Rs vs. D 2 receptors. Yet, all of them share high affinity for a 1 ARs (Arnt & Skarsfeldt, 1998 ; Bymaster et al. 1996 ; Meltzer, 1999) although the potential therapeutic role of a 1 AR blockade has been obscured by its involvement in cardiovascular side-effects.
Interestingly, functional interactions between 5-HT 2A and a 1 ARs have been reported, which may be involved in the therapeutic activity of antipsychotic drugs. Hence, neurochemical and behavioural actions of 5-HT 2A R agonists can be antagonized by 5-HT 2A R and a 1 AR blockade as well as by antipsychotic drugs Bortolozzi et al. 2003 ; Dursun & Handley, 1996 ; Schreiber et al. 1995) . Conversely, neurochemical effects of the a 1 AR agonist cirazoline in PFC can be reversed by prazosin, M100907 (a selective 5-HT 2A R antagonist) and by antipsychotic drugs . 5-HT 2A /a 1 AR interactions may also participate in the action of opiates and psychostimulants (Auclair et al. 2004) .
The cellular/network basis of the above interactions is unknown. Previous studies have revealed the presence of 5-HT 2A Rs in pyramidal and GABAergic neurons of rat PFC (Martín-Ruiz et al. 2001 ; Santana et al. 2004 ). However, the cellular expression of a 1 AR is presently unknown. Using double in situ hybridization, we performed a quantitative study on the expression of a 1A , a 1B and a 1D adrenergic receptors in pyramidal vesicular glutamate transporter 1 (vGluT1)-positive) and GABAergic (GAD 65/67 -positive) cells of rat PFC. Similarly, given the common signalling pathways shared by 5-HT 2A and a 1 ARs (Gq/11 G proteins) (Bartrup & Newberry, 1994 ; Berg et al. 1998 ; Claro et al. 1993 ; Michel et al. 1993 ; Molinoff, 1984) and the above functional interactions, we examined the co-expression of both receptors in rat PFC using double in situ hybridization.
Materials and method

Tissue preparation
Male albino Wistar rats weighing 250-300 g (Iffa Credo, France) were used. Animals were kept in a controlled environment [12-h light-dark cycle (lights on 08 : 00 hours) and 22¡2 xC room temperature] with food and water provided ad libitum. Animal care followed the European Union regulations (OJ of EC L358/1 18/12/ 1986) and was approved by the local Institutional Animal Care and Use Committee. Rats were killed by decapitation and the brains rapidly removed, frozen on dry ice and stored at x20 xC. Tissue sections, 14-mm thick, were cut using a microtome-cryostat (HM500 OM ; Microm, Germany), thaw-mounted onto 3-aminopropyltriethoxysilane-(APTS ; Sigma, USA) coated slides and kept at -20 xC until use.
Hybridization probes
The oligodeoxyribonucleotide probes used were complementary to the following bases : 2-46 and 1395-1439 of the rat a 1A AR mRNA (GenBank accession no. NM_017191.1) ; 365-409 and 2216-2260 of the rat a 1B AR mRNA (GenBank accession no. X51585.1) ; 1167-1212 of the rat a 1D AR mRNA (GenBank accession no. NM_024483.1) ; 128-170, 180-224, 836-880, 939-987, 1301-1345 and 1380-1427 of the rat 5-HT 2A R mRNA (GenBank accession no. NM_017254.1), 514-558 of the isoform of the enzyme glutamate decarboxylase (GAD 65 ) mRNA (GenBank accession no. NM_012563.1) ; 1600-1653 of the GAD 67 mRNA (GenBank accession no. NM_017007.1) ; 127-171 and 1756-1800 of the vGluT1 mRNA (GenBank accession no. NM_053859.1).
All probes were synthesized and HPLC purified by Isogen Bioscience BV (Maarsden, The Netherlands) and labelled either with 33 P or with digoxigenin (Dig). Each receptor oligonucleotide was individually labelled (2 pmol) at the 3k-end either with [ 33 P]dATP (>2500 Ci/ mmol ; DuPont-NEN, USA) using terminal deoxynucleotidyltransferase (TdT, Calbiochem, USA). GAD and vGluT oligonucleotides (100 pmol) were nonradioactively labelled with TdT (Roche Diagnostics GmbH, Germany) and Dig-11-dUTP (Boehringer Mannheim). Oligonucleotides were purified by centrifugation using ProbeQuant TM G-50 micro columns (GE Healthcare UK Ltd, UK). All probes were tested for specificity prior to use.
In situ hybridization histochemistry procedure
The protocol for single-and double-label in situ hybridization has been published elsewhere (Serrats et al. 2003) . Frozen tissue sections were first brought to room temperature, fixed for 20 min at 4 xC in 4 % paraformaldehyde in phosphate-buffered saline (1rPBS : 8 mM Na 2 HPO 4 , 1.4 mM KH 2 PO 4 , 136 mM NaCl, 2.6 mM KCl), washed for 5 min in 3rPBS at room temperature, twice for 5 min each in 1rPBS and incubated for 2 min at 21 xC in a solution of predigested pronase (Calbiochem, USA) at a final concentration of 24 U/ml in 50 mM Tris-HCl (pH 7.5), 5 mM EDTA. The enzymatic activity was stopped by immersion for 30 s in 2 mg/ml glycine in 1rPBS. Tissues were finally rinsed in 1rPBS and dehydrated through a graded series of ethanol. For hybridization, the radioactively labelled and the nonradioactively labelled probes were diluted in a solution containing 50 % formamide, 4rSSC (1rSSC : 150 mM NaCl, 15 mM sodium citrate), 1rDenhardt's solution (0.02 % Ficoll, 0.02 % polyvinylpyrrolidone, 0.02 % BSA), 10 % dextran sulfate, 1 % sarkosyl, 20 mM phosphate buffer (pH 7.0), 250 mg/ml yeast tRNA and 500 mg/ml salmon sperm DNA. The final concentrations of radioactive and Dig-labelled probes in the hybridization buffer were in the same range (y1.5 nM). Tissue sections were covered with hybridization solution containing the labelled probe(s), overlaid with Nescofilm coverslips (Bando Chemical Indistries, Japan) and incubated overnight at 42 xC in humidity boxes. Sections were then washed four times (45 min each) in a buffer containing 0.6 M NaCl and 10 mM Tris-HCl (pH 7.5) at 60 xC.
Development of radioactive and non-radioactive hybridization signal
Hybridized sections were treated as described by Landry et al. (2000) (see updated procedures in Santana et al. 2004 Santana et al. , 2009 ). Briefly, after washing, the slides were immersed for 30 min in a buffer containing 0.1 M Tris-HCl (pH 7.5), 1 M NaCl, 2 mM MgCl 2 and 0.5 % BSA (Sigma) and incubated overnight at 4 xC in the same solution with alkaline-phosphate-conjugated anti-digoxigenin-F(ab) fragments (1 : 5000 ; Boehringer Mannheim, Germany). Afterwards, they were washed three times (10 min each) in the same buffer (without antibody) and twice in an alkaline buffer containing 0.1 M Tris-HCl (pH 9.5), 0.1 M NaCl and 5 mM MgCl 2 . Alkaline phosphatase activity was developed by incubating the sections with 3.3 mg nitroblue tetrazolium and 3.3 mg bromochloroindolyl phosphate (Gibco BRL, USA) diluted in 10 ml alkaline buffer. The enzymatic reaction was blocked by extensive rinsing in the alkaline buffer containing 1 mM EDTA. The sections were then briefly dipped in 70 % and 100 % ethanol, air-dried and dipped into Ilford K5 nuclear emulsion (Ilford, UK) diluted 1 : 1 with distilled water. They were exposed in the dark at 4 xC for 5 wk and finally developed in Kodak D19 (Kodak, USA) for 5 min and fixed in Ilford Hypam fixer (Ilford).
Analysis of the results
Tissue sections were examined in bright-and dark-field in a Wild 420 macroscope (Leica, Germany) and in a Nikon Eclipse E1000 microscope (Nikon, Japan) equipped with bright-and dark-field condensers for transmitted light and with epi-illumination. Micrography was performed using a digital camera (DXM1200 3.0 ; Nikon) and analySIS software (Soft Imaging System GmbH, Germany). Bright-field images were captured with transmitted light. Dark-field images were captured with Darklite illuminator (Micro Video Instruments, USA). The figures were prepared for publication using Adobe Photoshop software (Adobe Software, USA). The cellular counting was performed with an Olympus AX70 stereo microscope using CAST software for stereological analysis, and an Olympus BX51 stereo microscope equipped with an Olympus microscope digital camera DP71 and Visiopharm Integrator System software (Olympus). Data for total a 1 AR expression was obtained by hybridizing PFC sections with a combination of the oligonucleotides selective for a 1A , a 1B and a 1D adrenergic receptor mRNA. Co-expression data of vGluT1, GAD, or 5-HT 2A R-positive cells (Dig-labelled cells) with a 1 AR mRNA (or individual a 1A , a 1D and a 1D adrenergic receptor mRNA) was estimated by counting the number of Dig-labelled cellular profiles which also expressed a 1 AR mRNA (radioactively labelled cells). Relative proportions were estimated by considering 100 % of the Dig-labelled cells. Only cellular profiles showing 2-fold density of silver grains from background were considered to be double-labelled. Data are means¡S.E.M. of three rats (duplicate/triplicate sections per rat, see Figure legends ).
Results
Expression of a 1 AR in the rat PFC
The various subtypes of a 1 AR mRNA were abundantly expressed in rat PFC, in particular a 1A and a 1D adrenergic receptors. Figure 1 shows the distribution of each individual a 1 AR transcript. Several features can be recognized. First, virtually all subdivisions of the PFC contained cells expressing one or more a 1 ARs. Second, most abundant transcripts were those corresponding to a 1A and a 1D adrenergic receptors, whereas the expression of a 1B AR was more moderate, particularly in the medial PFC (mPFC). Third, with few exceptions, the various a 1 AR transcripts showed an almost non-overlapping regional distribution within the mPFC. This was particularly remarkable for a 1A and a 1D adrenergic receptors. The former transcript was densely expressed in deep layers (VIa, VIb) of the medial, dorsal and lateral (agranular insular) PFC and the claustrum as well as in ventral areas, such as orbital and piriform cortices and the tenia tecta (TT). In contrast, the a 1D AR transcript was particularly abundant in intermediate layers (layers II-III, outer layer V) in medial and dorsolateral aspects of the PFC as well as in orbital cortex and had a much more restricted expression in TT and piriform cortex. In addition to this differential regional distribution (see Fig. 1 a, c) , there was a common expression of both receptors in superficial layers of medial and dorsolateral aspects of the PFC.
The density of the a 1B AR transcript was lower than that of a 1A ARs and a 1D ARs. Moreover, its regional distribution was more restricted, being localized to dorsal and lateral aspects of PFC (layers III-V), as well as orbital and piriform cortices.
Expression of a 1 ARs in pyramidal and GABAergic neurons of the rat PFC In double in situ hybridization experiments, we observed the presence of all three types of a 1 ARs in pyramidal (vGluT1-positive) and GABAergic (GAD 65/67 -positive) neurons. Figures 2-4 show representative examples of the presence of a 1A , a 1B and a 1D adrenergic receptor transcripts in pyramidal and GABAergic neurons in various layers of the mPFC. Note the abundance of pyramidal and GABAergic neurons expressing a 1A and a 1D adrenergic receptors. Table 1 shows the proportion of pyramidal and GABAergic neurons in the cingulate, prelimbic and infralimbic areas of the mPFC expressing a 1 ARs.
The proportion of pyramidal neurons expressing a 1 ARs in the different cortical layers and areas of the mPFC was very high (59-85 %), being maximal in layers II-III and V of the cingulate and prelimbic areas (71-85 %) (Table 1) . There was a dorsoventral gradient in the proportion of pyramidal cells expressing a 1 ARs, with a greater percentage in the anterior cingulate and a lower proportion in the infralimbic area, particularly in layer VI (Table 1) .
Similarly, a very high proportion of GABAergic neurons also expressed a 1 ARs (52-79 %). GABAergic cells expressing each of the three a 1 AR subtypes were found in different cortical layers, including layer I. Figures 2-4 show representative examples of GABAergic cells expressing a 1A , a 1B and a 1D adrenergic receptors in the mPFC. Interestingly, unlike the other a 1 AR subtypes, some cells in superficial layers of the prelimbic area exhibited a remarkably high level of the a 1B AR transcript (data not shown).
Further analysis of the regional expression of the different a 1 AR subtypes revealed that pyramidal neurons expressing a 1A ARs were more abundantly localized in deep layers (V-VI) in the three mPFC subdivisions (ACAd, PL, ILA) (layer factor : F 1,12 =35.7, p<0.0001 ; region factor : n.s. ; two-way ANOVA). No effect of layer and region was found for a 1A ARs expressed in GABAergic neurons. In contrast, pyramidal neurons expressing a 1D ARs were mainly localized in superficial layers (II-III) in the same regions (layer factor : F 1,12 = 453.7, p<0.0001 ; region factor : F 1,12 =6.7, p<0.05 ; http://ijnp.oxfordjournals.org/ two-way ANOVA) ( Fig. 5 ). GABAergic neurons expressing a 1D AR were also localized in superficial layers (layer factor : F 1,12 =53.3, p<0.0001 ; region factor : F 1,12 =8.6, p<0.05 ; two-way ANOVA) ( Fig. 5 ).
Co-expression of a 1 ARs and 5-HT 2A Rs in rat PFC
The regional distribution of a 1 AR and 5-HT 2A R mRNA was very similar in PFC (Fig. 6 ). Figure 6 b corresponds to the combined expression of all three a 1 AR subtypes, obtained by hybridizing PFC sections with a combination of the oligonucleotides selective for a 1A , a 1B and a 1D adrenergic receptor mRNA, as described in the Method section.
With the exception of layer VI, and the more ventral part of the infralimbic cortex, with low 5-HT 2A R mRNA expression, virtually all other areas in PFC showed an abundant expression of both receptor transcripts. These areas included the cingulate and prelimbic areas of the mPFC, motor, agranular insular, orbital and piriform cortices, and TT. (See Fig. 1 for a detailed comparison of the expression of 5-HT 2A Rs with each one of the three a 1 AR subtypes.) Double in situ hybridization experiments were conducted to examine the possible cellular co-localization of 5-HT 2A R with a 1A , a 1B and a 1D adrenergic receptors, as well as with the three subtypes together (total a 1 AR). Figures 6 and 7 show the extensive cellular co-expression of 5-HT 2A Rs with a 1 ARs, especially with a 1A AR, and a 1D AR subtypes, in various fields of the mPFC as well as in other PFC areas such as piriform cortex, TT or agranular insular cortex. We performed a detailed estimation of the percentage of cellular co-expression of 5-HT 2A Rs with a 1 ARs in layers II-III of the mPFC (cingulate, prelimbic, infralimbic areas) (Fig. 8) . Given the limited expression and restricted localization of a 1B ARs, we did not carry out the cellular counting of this receptor subtype. Taking 5-HT 2A -expressing cells as 100 %, the (b) Cells expressing one or more type of a 1 ARs were still more abundant than those expressing 5-HT 2A Rs. Virtually all areas of the PFC showed the presence of a 1A , a 1B , and a 1D adrenergic receptor mRNA. Open squares indicate the approximate location of areas where co-expression of both receptors was examined (Fig. 6 ). Bar size, 1 mm. Fig. 7 . Co-localization of 5-HT 2A mRNA (Dig-labelled oligonucleotides, dark precipitates) with the different types of a 1 adrenergic receptor (AR) mRNA ( 33 P-labelled oligonucleotides, silver grains) in various areas of the rat prefrontal cortex (PFC).
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(A1-A3) Co-localization with a 1A ARs in the prelimbic cortex ; Panels A1 and A3 show, at different magnification, cells expressing both receptors mRNA in layers II-III whereas panel A2 shows some cells in layer VI. Note the presence of cells positive for a 1A ARs and negative for 5-HT 2A Rs (blue arrowheads), as expected from the scarcity of cells expressing 5-HT 2A Rs and abundance of a 1A ARs in deep layers. (B1-B3) Co-localization of 5-HT 2A Rs with a 1B ARs in layers II-III of the anterior cingulate (B1 and B3) and prelimbic (B2) cortices. As expected from the negative dorsoventral gradient of expression of a 1B ARs in the mPFC, there was a greater co-expression in cingulate cortex. (C1-C3) Co-localization of 5-HT 2A Rs with a 1D ARs in layers II-III of the anterior cingulate (C1 and C3) and layer VIb of the prelimbic cortex (C2). Note the absence of the a 1D AR transcript in deep layers, and consequently, the low level of co-expression with 5-HT 2A Rs. (D1-D3) Co-localization of 5-HT 2A R mRNA with a 1A , a 1B , and a 1D adrenergic receptor mRNA (multiple probes). Panels D1 and D3 correspond to layers II-III and panel D2 corresponds to layer VI, all in prelimbic cortex. Regarding individual a 1 AR mRNA, note the low co-expression in layer VI due to the small number of 5-HT 2A -positive cells in this area. Several cells positive for one or more a 1 AR mRNA (e.g. the a 1A subtype) and negative for 5-HT 2A R mRNA are indicated with blue arrowheads. Panels E1-E3 show the high co-expression of both receptors in areas other than the mPFC. Panel E1 shows the co-localization of the 5-HT 2A R mRNA with a 1A AR mRNA in tenia tecta. Panels E2 and E3 show, respectively, the co-localization of 5-HT 2A R mRNA with a 1 AR mRNA (multiple probes) in the piriform cortex and the ventral part of the agranular insular cortex. Bar size, 20 mm.
percentage of cells also expressing a 1 ARs varied between 44 % in the infralimbic area to 75 % and 80 %, respectively, in the prelimbic and cingulate areas. Given the preferential expression of a 1D ARs in superficial layers, where cell counts were performed, this subtype was probably the one contributing most to co-expression with 5-HT 2A Rs. However, it is likely that similar counts performed in areas showing abundant expression of 5-HT 2A Rs and a 1A ARs, such as the motor area or the agranular insular cortex, would also give very high levels of co-expression, as shown in Fig. 6 .
Discussion
The present study shows that a 1 AR mRNA is expressed in rat PFC in a very high proportion of pyramidal neurons and local GABAergic interneurons. The three a 1 AR subtypes show a complementary and almost non-overlapping distribution in the different PFC subdivisions and layers, which suggests specific roles for each a 1 AR in the various PFC functions. Interestingly, cells expressing a 1A ARs were significantly more abundant in deep layers whereas cells expressing a 1D ARs were much more abundant in superficial layers, suggesting that the former receptors are involved in the control of subcortical structures. Each a 1 AR type was extensively co-expressed with 5-HT 2A Rs, which indicates a convergence of excitatory noradrenergic and serotonergic signals in the same PFC neurons. To our knowledge, this is the first study examining the cellular localization of a 1 AR mRNA in mammalian PFC. It adds to similar studies on 5-HT and dopamine receptors relevant for antipsychotic drug action (Amargó s-Bosch et al. 2004 ; Puig et al. 2004 ; Santana et al. 2004 Santana et al. , 2009 ). The three a 1 AR types occur in various cortical areas (Day et al. 1997 ; Palacios et al. 1987 ; Pieribone et al. 1994) . When examined in a study by Pieribone et al. (1994) , their regional distribution coincides essentially with the present observations. The use of double in situ hybridization enabled us to quantify the proportion of pyramidal and GABAergic neurons expressing each a 1 AR type. Interestingly, the proportion of each neuronal type expressing one or more types of a 1 AR was surprisingly high (80-86 %), compared to 5-HT 1A , 5-HT 2A , 5-HT 3 , 5-HT 4 or dopamine D 1 and D 2 receptors in rat PFC using the same methodology (maximum of 66 % for 5-HT 2A Rs in ACAd) Santana et al. 2004 Santana et al. , 2009 T. Vilaró , personal communication) .
The difference between the proportion of PFC GABAergic interneurons expressing a 1 ARs or other monoaminergic receptors is even more marked. Hence, a maximal proportion of 32-34 % GABAergic neurons in ACAd/PL express 5-HT 2A Rs . Moreover, 5-HT 3 Rs, which are exclusively expressed by GABAergic interneurons in PFC and hippocampus (Morales et al. 1996 ; Puig et al. 2004 ) are present in 6-40 % of GABAergic neurons in different cortical layers . Similarly, dopamine D 1 and D 2 receptor mRNA is present in 5-38 % of GABAergic neurons in various PFC subdivisions (Santana et al. 2009 ). However, the different a 1 ARs were expressed in a much higher proportion of GABAergic interneurons, similar to that in pyramidal neurons (69-74 % in superficial layers ; 52-73 % in deep layers). Overall, the presence of a 1 ARs in such a large proportion of pyramidal and GABAergic neurons suggests that NE can modulate the activity of most PFC output neurons via direct or indirect actions, a view consistent with electrophysiological observations, some of which are common with those of 5-HT 2A R activation (Araneda & Andrade, 1991 ; . Moreover, the presence of 5-HT 2A Rs and a 1 ARs in GABAergic interneurons indicates that 5-HT and NE may play a prominent role in the control of local PFC networks, as observed in electrophysiological experiments. Hence, both NE and 5-HT can inhibit the activity of layer V pyramidal cells via activation of 5-HT 2A Rs and a 1 ARs in fast-spiking GABAergic cells (Kawaguchi & Shindou, 1998 ; Puig et al. 2010 ; Weber & Andrade, 2010 ; Zhong & Yan, 2011) .
The NE-evoked excitations of pyramidal neurons involve post-synaptic a 1 ARs. However, there have been controversial views on the localization of 5-HT 2A Rs in PFC. Hence, while some studies suggested a presynaptic localization on thalamocortical afferents (Aghajanian & Marek, 1997 , subsequent studies did not support this view (Beique et al. 2007 ; Miner et al. 2003 ; Puig et al. 2003) , indicating a predominant post-synaptic localization of 5-HT 2A Rs in PFC neurons, in common with a 1 ARs. A recent paper showed the presence of a 1 AR immunoreactivity in vGluT1-positive glutamatergic axons in PFC (Mitrano et al. 2012) . This observation would be consistent with the presence of a large proportion of layer III neurons expressing a 1 AR transcripts (present study), suggesting that NE may also modulate intracortical connectivity through presynaptic excitatory a 1 ARs. The markedly high co-expression of 5-HT 2A R mRNA with that of a 1 ARs suggests a convergence of excitatory signals evoked by 5-HT and NE on PFC neurons. Given the different proportion of GABA cells expressing 5-HT 2A Rs and a 1 ARs, it is likely that most of the coexpression takes place in pyramidal neurons. Indeed, immunohistochemical studies have shown that a 1 ARs and 5-HT 2A Rs are localized in cell bodies and apical dendrites of pyramidal neurons (Acosta-Martinez et al. 1999 ; Cornea-Hebert et al. 1999 ; Jakab & Goldman-Rakic, 1998 , 2000 Martin-Ruiz et al. 2001) . Further, functional interactions have been reported between 5-HT 2A Rs and a 1 ARs in the rat (see Introduction). These observations, together with the common signalling pathways and their functional interactions, suggest a close association between both receptors. Whether this involves the formation of stable heteromers, as observed with other neurotransmitter receptors, remains to be established. Preliminary data indicate that 5-HT 2A Rs coimmunoprecipitate and show stable fluorescence resonance energy transfer (FRET) signals with all three a 1 ARs expressed in HEK-293T cells (Santana et al. unpublished observations) . However, this is just a first step in establishing the formation of receptor heteromers in vivo (Ferré et al. 2009 ).
The present observations may have important physiological and therapeutic implications. On the one hand, PFC neuronal activity may be concurrently regulated by the ascending 5-HT and noradrenergic systems. Since both neuronal groups are REM-off (Aston-Jones et al. 1991 ; Jacobs & Azmitia, 1992 ) the concurrent activation (or its lack) of excitatory a 1 ARs and 5-HT 2A Rs in the same cells may have a synergistic effect on the activity of cortical neurons during wakefulness and sleep. Moreover, both receptors have been involved in working memory through the modulation of neuronal activity in dorsolateral PFC (Ramos & Arnsten, 2007 ; Williams et al. 2002) . On the other hand, dual reuptake inhibitors (Artigas, 1995) show an antidepressant efficacy higher than selective 5-HT reuptake inhibitors, an effect which may occur via summation of effects on the same cortical neurons. Finally, conventional and second-generation (atypical) antipsychotics share the ability to antagonize a 1 ARs while the latter drugs also antagonize 5-HT 2A Rs (Arnt & Skarsfeldt, 1998 ; Bymaster et al. 1996) . The therapeutic potential of a 1 AR blockade in schizophrenia has been neglected due to its cardiovascular effects, despite the fact that prazosin enhanced the antipsychotic actions of dopamine D 2 receptor blockade (Wadenberg et al. 2000) . The present observations support the view that a 1 AR and 5-HT 2A R blockade may add to each other to modulate PFC function making the PFC a particularly sensitive area to the action of atypical antipsychotic drugs (Artigas, 2010) .
In summary, the present study shows that the ascending 5-HT and NE systems share common actions in the PFC through the concurrent expression of a 1 ARs and 5-HT 2A Rs in most PFC neurons, an observation with potential physiological and pharmacological consequences.
